Founded in 2019, ErlySign operates in Health Tech industry. Initially concentrating on easy-to-use cancer detection diagnostics, the company has expanded its focus to include a broader array of biotec...
Funding stage:
Pre-Series A
Last funding:
14/01/2025
Total funding:
$2.00 Mn+
Revenue:
Investors
Employee count:
14
Last 90d
14
Last 90d
ErlySign: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders12
Latest Filing Date25 Dec 2024- Funding Events12
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of ErlySign
As of 26 December 2024, ErlySign's equity is held by 11 shareholders, with the top three being Shubhendra Singh Thakur, Deovrat Begde, and Ashish Kacholia.
Shubhendra Singh Thakur holds the largest stake in ErlySign at 27.9% as of 26 December 2024.
As of 26 December 2024, founders collectively hold 46.4% equity in ErlySign.
As of 26 December 2024, investors collectively hold 25.7% equity in ErlySign.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links